March 22, 2023 - Cellular Therapies

March 22, 2023
Please note, access to symposium recordings is included with registration.
Access will be available for 30 days post event.

With several new drug and cellular therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic malignancies, there is a need for ongoing education in the area of hematologic malignancies. This interactive webinar series will focus on current best practices and major updates in the biology, diagnosis, and management of hematologic malignancies.

Each 90-minute webinar will have two talks followed by 30 minutes of discussion and audience questions. Presenters will include internationally-known disease experts from Mass General Cancer Center covering practice-changing updates in cellular therapies, transplant, myeloma, leukemia, and lymphoma.

Target Audience

This activity is intended for physicians, nurses, physician assistants, other members of healthcare team (regional) with specialties such as general practice, hematology, hematology/oncology, medical oncology, primary care, and radiation oncology.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss practice-changing updates in cellular therapy
  2. Identify new cellular therapies and indications for cellular therapy

Additional Information

Provided by: 

Massachusetts General Hospital Cancer Center & Mass General Brigham

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Nursing Contact Hours
  • 1.50 Participation
Course opens: 
09/22/2022
Course expires: 
04/22/2023
Event starts: 
03/22/2023 - 5:00pm EDT
Event ends: 
03/22/2023 - 6:30pm EDT
Cost:
$45.00
5:00pm

Cellular Therapy in Lymphoma
Jeremy Abramson, MD

5:30

Cellular Therapy Updates in Myeloma & Leukemia
Matt Frigault, MD

6:00

Q&A/Discussion

6:30Adjourn

COURSE DIRECTOR

P. Connor Johnson, MD
Hematology/Oncology, Massachusetts General Hospital Cancer Center
Instructor in Medicine, Harvard Medical School

 

Speakers

 

Jeremy Abramson, MD
Director, Jon and Jo Ann Hagler Center for Lymphoma, Massachusetts General Hospital Cancer Center
Associate Professor of Medicine, Harvard Medical School

Matt Frigault, MD
Administrative Director, Cellular Therapy Service, Massachusetts General Hospital Cancer Center
Assistant Professor of Medicine, Harvard Medical School

 

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing
Mass General Brigham designates this activity for 1.5 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants
Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Nursing Contact Hours
  • 1.50 Participation

Price

Cost:
$45.00
Please login or register to take this course.

CANCELLATION POLICY:

Registrations cancelled on or before March 8, 2023 will be refunded, less a $15 administrative fee. Registrations cancelled after March 8, 2023 will not be refunded.

Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.